# Peginterferon Alpha-2a Maintenance Therapy for Portal Hypertension in Patients With Hepatitis C

> **NCT00252642** · NA · COMPLETED · sponsor: **Virginia Commonwealth University** · enrollment: 60 (actual)

## Conditions studied

- Hepatitis C
- Cirrhosis
- Fibrosis

## Interventions

- **DRUG:** Peginterferon Alpha-2a

## Key facts

- **NCT ID:** NCT00252642
- **Lead sponsor:** Virginia Commonwealth University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-11
- **Primary completion:** 2007-09
- **Final completion:** 2007-09
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2017-03-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00252642

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00252642, "Peginterferon Alpha-2a Maintenance Therapy for Portal Hypertension in Patients With Hepatitis C". Retrieved via AI Analytics 2026-09-08 from https://api.ai-analytics.org/clinical/NCT00252642. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*